New hope for advanced breast cancer: EP0062 trial begins
NCT ID NCT05573126
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study tests a new drug called EP0062 in people with advanced breast cancer that has come back after treatment. The goal is to find the best dose and see if it is safe and works, either alone or with other standard treatments. About 95 adults with a specific type of breast cancer (AR+/HER2-/ER+) will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henry Ford Hospital
RECRUITINGDetroit, Michigan, 48202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Hospital 12 de Octubre
RECRUITINGUsera, Madrid, 28041, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitari Vall d'Hebron (VHIO)
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, 28034, Spain
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-••••
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NEXT Oncology Hospital Quironsalud
RECRUITINGMadrid, 28223, Spain
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sarah Cannon Research Institute UK
RECRUITINGLondon, London, W1G 6AD, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Texas Oncology Baylor University Medical Center
RECRUITINGDallas, Texas, 75246, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Christie NHS Foundation Trust
RECRUITINGManchester, Wilmslow Rd, M20 4BX, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Clatterbridge Cancer Centre
RECRUITINGLiverpool, CH63 4JY, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yale School of Medicine
COMPLETEDNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.